Form D · Biotechnology

ACS Global, Inc.

Red Bank, NJ · CIK 0001423912

Offering snapshot reported Jul 1, 2011 · SEC filing

Reported sold
$2.23M
Offering amount: $3M
Investors reported
62
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
Mar 11, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.12M$2.23MDec 2, 2009: $225,000.00Dec 2, 2009Jul 1, 2011: $2,232,000.00Jul 1, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$225,000 → $2,232,000
  • Reported investors30 → 62

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 1, 2011Amendment$2,232,000$2,007,000vs Dec 2, 200962SEC filing
Dec 2, 2009Initial$225,000No comparison30SEC filing
Nov 17, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 14, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-113401

Source: Form D, filed Jul 1, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Stephen Arnone Director, Executive
Anthony Dudzinski Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
188 East Bergen Place Suite 204
Red Bank, NJ, 07701